This means that passive immunization with tau antibodies is actually a viable therapeutic concentrate on and which the CSF standard of p-tau262/356 or on the microtubule binding area (MTBD) can function a practical biomarker of tau pathology to watch tau therapeutics in medical trials. Aesthetics